Moderna has decided to shift production to its own facilities in the US and elsewhere.
Gaetan Bally
Swiss pharmaceutical supplier Lonza will stop production of the Covid-19 vaccine for Moderna at its Visp site in the third quarter of 2023. Moderna will cover its demand for the vaccine from its own production facilities in the future, the US company announced on Tuesday.
This content was published on
1 minute
Keystone-SDA
US vaccine maker Moderna is focusing production of the mRNA agent at fewer sites as demand has declined with the transition from a pandemic to an endemic market, the statementExternal link added. Lonza could not initially be reached for comment by the Swiss business news agency AWP.
Moderna will meet vaccine demand for 2024 and 2025 from its own sites in Norwood, Massachusetts, it said. More capacity will be added starting in 2025 when Moderna’s new mRNA production facilities in the UK, Canada and Australia come online, according to the statement.
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles. You can find them here.
If you want to know more about how we work, have a look here, and if you have feedback on this news story please write to english@swissinfo.ch.
External Content
Your subscription could not be saved. Please try again.
Almost finished… We need to confirm your email address. To complete the subscription process, please click the link in the email we just sent you.
Popular Stories
More
Swiss Abroad
An eye-opening guide to Switzerland’s ear-splitting sirens
Tibetans and Uyghurs in Switzerland face pressure from China
This content was published on
Tibetans and Uyghurs living in Switzerland are probably under pressure from China and are being encouraged to spy on their community, according to the Swiss government.
Swiss federal accounts CHF2.5 billion better than expected
This content was published on
A deficit of CHF80 million instead of the budgeted CHF2.6 billion: for the first time since the Covid pandemic, the Swiss government has almost balanced its books
Swiss government specifies reconstruction aid in Ukraine
This content was published on
Reconstruction of urban infrastructure, restoration of secure basic services, continuation of emergency aid: these are the goals of the Swiss government in Ukraine over the next few years.
Swiss government wants to adopt Council of Europe AI conventions
This content was published on
The Swiss government wants to incorporate the Council of Europe's conventions on artificial intelligence (AI) into Swiss law.
Swiss government wants more leeway to export war materiel
This content was published on
The Swiss parliament will decide on whether the government is to be given more leeway in authorising exports of war materiel if the situation requires it.
Ai Weiwei expresses surprise at being turned away at Zurich Airport
This content was published on
The world-famous artist was stopped when he entered Switzerland on Monday evening because, according to the Zurich police, he did not have a visa.
This content was published on
Director General Tedros Adhanom Ghebreyesus says the American "absence" on the executive board since last week makes him "sad".
Number of bearded vultures in the Alps could double in ten years
This content was published on
The bearded vultures in the Alps are currently doing so well that their population could double to around 700 animals within ten years.
Hardly any violations of minimum wage regulations in Ticino
This content was published on
A good 3% of companies inspected have violated the minimum wage in the Swiss canton of Ticino in the past three years, according to an official review.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Explainer: should we be worried about the Covid-19 comeback?
This content was published on
Switzerland and the US have issued Covid-19 vaccination recommendations for this winter. Here is what we know so far about variants and vaccines.
Lonza to double production of Covid-19 vaccine at Swiss plant
This content was published on
The Swiss firm will add three more production lines to its plant as part of a larger effort to boost Moderna’s global supply of vaccine doses.
New Lonza site can now make Covid-19 vaccine ingredient
This content was published on
Swissmedic, the Swiss Agency for Therapeutic Products, has approved Lonza’s new site for making Moderna’s Covid-19 active substance.
Vaccines and beyond: How AI is shaping our pandemic response
This content was published on
The race to vaccinate against Covid-19 has science running at full speed, unravelling age-old mysteries with the help of artificial intelligence (AI).
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.